Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-OncologyCarlo G. Tocchetti, Teresa López‐Fernández, Alexander R. Lyon et al.|European Journal of Heart Failure|2024Cited by 64
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic EffectsJoerg Herrmann, Joshua D. Mitchell, Ana Barac et al.|JAMA Oncology|2025Cited by 10